1 | DEXMEDETOMIDINE (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 |
2 | Dexmedetomidine 1 (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
3 | Dexmedetomidine 2 (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
4 | Dexmedetomidine 3 (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
5 | Dexmedetomidine group (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
6 | Dexmedetomidine Hcl 100 Mcg/mL Inj (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
7 | DEXMEDETOMIDINE HYDROCHLORIDE (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
8 | Dexmedetomidine Hydrochloride Infusion (Synonym: D00514) | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
9 | Dexmedetomidine with ropivacaine (Synonym: D00514) | 2件: Dexmedetomidine Dexmedetomidine, Ropivacaine | 2件: D00514
D00514
,
D08490
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
10 | Fentanyl (Low Dose) + Dexmedetomidine (Synonym: D00514) | 2件: Dexmedetomidine Dexmedetomidine, Fentanyl | 2件: D00320
D00320
,
D00514
| 4件: ADRA2A ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | 4件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
11 | Scopolamine, atropine, edaravone and dexmedetomidine (Synonym: D00514) | 4件: Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | 4件: D00113
D00113
,
D00138
,
D00514
,
D01552
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |